Can enoxaparin reduce thromboembolism related events after primary TKA in Asian patients?
J Arthroplasty
; 28(10): 1862-7, 2013 Dec.
Article
en En
| MEDLINE
| ID: mdl-23683524
ABSTRACT
The purpose of this study was to investigate the efficacy and safety of enoxaparin in preventing venous and arterial thromboembolism related events after primary total knee arthroplasty (TKA) in Asian patients. Four hundred twenty nine patients (621 TKAs) did not receive thromboprophylaxis after TKA and 907 patients (1,336 TKAs) received enoxaparin after the procedure. We assessed clinically significant venous and arterial thromboembolism related events and bleeding complications. Total thromboembolism related events occurred in 13 patients (3.03%) without thromboprophylaxis and 17 patients (1.87%) with enoxaparin (P = 0.183). Our study showed that the incidence of clinically significant thromboembolism related events after TKA was very low in Asian patients. Enoxaparin had no benefits in reducing thromboembolism related events in Asian patients.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Artritis
/
Tromboembolia
/
Enoxaparina
/
Artroplastia de Reemplazo de Rodilla
/
Fibrinolíticos
/
Articulación de la Rodilla
Tipo de estudio:
Etiology_studies
Límite:
Aged
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
J Arthroplasty
Asunto de la revista:
ORTOPEDIA
Año:
2013
Tipo del documento:
Article
País de afiliación:
Corea del Sur